Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was Recruiting

Sponsor:

Information provided by (Responsible Party):

King Faisal Specialist Hospital & Research Center

ClinicalTrials.gov Identifier:

NCT01310959

First received: March 6, 2011

Last updated: December 11, 2011

Last verified: December 2011

History of Changes

Purpose

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Condition	Intervention
Aplastic Anemia and Other Marrow Failure Syndrome	Other: Database


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Retrospective
Official Title:	Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Resource links provided by NLM:

MedlinePlus related topics: Anemia Aplastic Anemia

Genetic and Rare Diseases Information Center resources: Aplastic Anemia

U.S. FDA Resources

Further study details as provided by King Faisal Specialist Hospital & Research Center:


Estimated Enrollment:	88
Study Start Date:	January 2003

Intervention Details:

Database

Other Name: Database

Detailed Description:

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Eligibility


Ages Eligible for Study:	14 Years to 85 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Aplastic Anemia and Other Marrow Failure Syndrome Database

Criteria

Inclusion Criteria:

Patients with diagnosed Aplastic Anemia and Other Marrow Failure Syndrome Database.

Exclusion Criteria:

Patients with diagnosis other than Aplastic Anemia and Other Marrow Failure Syndrome Database.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01310959

Contacts


Contact: H Al-Zahrani, M.D.	+966-1-4423949

Locations


Saudi Arabia
Kfsh & Rc	Recruiting
Riyadh, Saudi Arabia

Sponsors and Collaborators

King Faisal Specialist Hospital & Research Center

Investigators


Principal Investigator:	H Al-Zahrani, M.D.	KFSH & RC

More Information

No publications provided


Responsible Party:	King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:	NCT01310959 History of Changes
Other Study ID Numbers:	RAC# 2021-084, RAC# 2021-084
Study First Received:	March 6, 2011
Last Updated:	December 11, 2011
Health Authority:	United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:


Aplastic Anemia Marrow Failure Syndrome

Additional relevant MeSH terms:


Anemia, Aplastic Anemia Bone Marrow Diseases Hematologic Diseases

ClinicalTrials.gov processed this record on March 03, 2015

To Top